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Virulent C. difficile toxins TcdA and TcdB invade host intestinal epithelia by endocytosis
and use the acidic environment of intracellular vesicles for further processing and
activation. We investigated the role of ClC-5, a chloride/proton exchanger expressed
in the endosomes of gastrointestinal epithelial cells, in the activation and processing
of C. difficile toxins. Enhanced intoxication by TcdA and TcdB was observed in cells
expressing ClC-5 but not ClC-4, another chloride/proton exchanger with similar function
but different localization. In accordance with the established physiological function of
ClC-5, its expression lowered the endosomal pH in HEK293T cells by approximately
0.6 units and enhanced approximately 5-fold the internalization of TcdA. In colon
HT29 cells, 34% of internalized TcdA localized to ClC-5-containing vesicles defined by
colocalization with Rab5, Rab4a, and Rab7 as early and early-to-late of endosomes but
not as Rab11-containing recycling endosomes. Impairing the cellular uptake of TcdA
by deleting the toxin CROPs domain did not abolish the effects of ClC-5. In addition,
the transport-incompetent mutant ClC-5 E268Q similarly enhanced both endosomal
acidification and intoxication by TcdA but facilitated the internalization of the toxin
to a lower extent. These data suggest that ClC-5 enhances the cytotoxic action of
C. difficile toxins by accelerating the acidification and maturation of vesicles of the
early and early-to-late endosomal system. The dispensable role of electrogenic ion
transport suggests that the voltage-dependent nonlinear capacitances of mammalian
CLC transporters serve important physiological functions. Our data shed light on
the intersection between the endocytotic cascade of host epithelial cells and the
internalization pathway of the large virulence C. difficile toxins. Identifying ClC-5 as a
potential specific host ion transporter hijacked by toxins produced by pathogenic bacteria
widens the horizon of possibilities for novel therapies of life-threatening gastrointestinal
infections.
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INTRODUCTION
The spore-producing gram-positive bacterium Clostridium
difficile (C. difficile) is one of the leading causes of healthcare-
related infections. The symptoms of C. difficile infections
(CDI) range from light to very severe and life-threatening
antibiotic-associated diarrhea and pseudomembranous colitis.
C. difficile bacteria produce two main virulence proteins, the
large glucosyltransferases Toxin A (TcdA) and Toxin B (TcdB).
These toxins play a central role in the development of the
bacterial pathogenicity at the cellular level and of the clinical
symptoms at the whole organism level. (Voth and Ballard, 2005)
The major cytotoxic effects of TcdA and TcdB develop through
a cascade of events that can be divided into three major steps:
(a) binding, (b) endocytosis, and (c) translocation and release of
the toxin’s N-terminus from the endosomes into the host cytosol
(Tucker and Wilkins, 1991; Jank et al., 2007; Papatheodorou
et al., 2010). The activated toxin N-termini produced in the
last step inactivate members of the Ras superfamily of small
GTPases via glucosylation (Pfeifer et al., 2003; Just and Gerhard,
2005; Jank et al., 2007; Pruitt et al., 2010). Toxin-mediated
inactivation of the small GTPases leads to disorganization of
the cytoskeleton and changes in cell morphology, often denoted
as cell rounding (Just et al., 1995; Nottrott et al., 2007). This
particular step is relatively well described and represents one
of the major mechanisms underlying the cytopathic effects
of TcdA and TcdB. The preceding events have been also
intensively investigated. It is known that at least two host receptor
proteins support toxin attachment to the surface membrane of
attacked cells (LaFrance et al., 2015; Yuan et al., 2015). The
subsequent internalization includes (but is not restricted to) the
clathrin-mediated endocytosis (CME) pathway (Papatheodorou
et al., 2010; Gerhard et al., 2013; Chandrasekaran et al., 2016).
Importantly, V-ATPase-dependent acidification of endocytotic
vesicles seems to be essential for the following cytotoxic effects;
it triggers significant conformational changes of TcdA and TcdB
that lead to the formation of channels in the vesicle’s membrane
and allow the toxin N-termini to access the cytosol (Barth et al.,
2001; Giesemann et al., 2006; Schwan et al., 2011).
In light of the permissive role of vesicular acidity for the
cytopathic action of bacterial toxins, we set out to investigate the
potential involvement of the human Cl−/H+ exchanger ClC-5
in the processing and activation of C. difficile TcdA and TcdB.
The choice was motivated by the importance of ClC-5 for the
processes of endocytosis and endosomal acidification (see for
a review Jentsch, 2008). ClC-5 is a Cl−/H+ exchanger (Picollo
and Pusch, 2005; Scheel et al., 2005) that is expressed and
physiologically active in cells constituting the gastrointestinal
epithelial barrier attacked by C. difficile toxins. Specifically, ClC-
5 has been found in early and early-to-late endosomes in rat
intestinal epithelial cells (Vandewalle et al., 2001). In gastric
parietal cells, ClC-5 has been shown to associate with theH+/K+-
ATPase and to increase the activity of gastric proton pumps
(Takahashi et al., 2014). The physiological role of ClC-5 has
been controversially discussed. There is evidence that it provides
counter-ions to enhance the acidification of endosomes, a process
that is actively driven by the vesicular proton pumps (V-ATPases)
(Lloyd et al., 1996; Piwon et al., 2000; Wang et al., 2000).
However, it has been also proposed that ClC-5 can directly
acidify endosomes by its Cl−/H+ exchange function (Smith and
Lippiat, 2010a). The principles of operation of these proteins
have been also extensively investigated and it is known that
the CLC transport activity critically depends on two glutamate
residues, the so-called gating glutamate at position E211 (Picollo
et al., 2010) and the so-called proton glutamate at position E268
(Zdebik et al., 2008).
It is important to note that increased severity and higher
mortality rates are associated with CDI in patients with
inflammatory bowel disease (IBD) (Issa et al., 2008). Remarkably,
increased expression of ClC-5 has been detected in IBD patients
and in mice with experimentally induced colitis. Vice versa,
increased susceptibility to dextran sulfate sodium-induced colitis
was found in Clcn5 knockout mice. (Sullivan et al., 2009;
Alex et al., 2010) These data additionally support the notion
that human ClC-5 might be involved in the development of
C. difficile-induced cytotoxicity and the pathophysiology of
CDI. To test this hypothesis, we expressed human ClC-5 in
HEK293 and colon HT29 cells and elucidated the effects of this
manipulation on the endocytosis and cellular effects of TcdA
and TcdB.
RESULTS
ClC-5 Expression Increases Susceptibility
to Intoxication by TcdA and TcdB in an
Acidification-Dependent Manner
We first investigated the cytotoxic effects of the more potent
C. difficile toxin, TcdB, on HEK293 cells stably expressing
ClC-5 (Figure 1). The TcdB-induced disruption of the actin
cytoskeleton is readily observed as changes in the form and
morphology of the affected cells (Just et al., 1995; Nottrott et al.,
2007). Figure 1A shows representative images of untreated cells
and cells intoxicated with 10 pM TcdB. Control cells stably
transfected with the fluorescent protein mCherry were almost
unaffected by the applied toxin concentration. In contrast, a
significant percentage of the cells expressing ClC-5 exhibited
roundish form (Figure 1A, see also Supplementary Figure S1
for effects on colon HT29 cells). We also applied TcdB on
cells stably expressing ClC-4. ClC-4 is relevant for the central
nervous system; it is closely related to ClC-5 but mainly found
in membranes of the endoplasmic reticulum (Okkenhaug et al.,
2006; Veeramah et al., 2013; Hu et al., 2016). At the used TcdB
concentration, ClC-4-expressing cells behaved similarly as the
mCherry-expressing cells, suggesting that the role of ClC-5 is
specific.
The action of C. difficile toxins can be conveniently observed
in the time domain by monitoring the transepithelial resistance
(TER) of confluent epithelial cell layers (Gerhard et al., 1998).
In particular, the TER is defined by the barrier integrity of
epithelia with tight junctions. A decrease of the TER indicates
disruption of the barrier function and an increase in epithelial
paracellular permeability. Applying the method onMadin-Darby
canine kidney cells (MDCK II) cultivated to confluency on filter
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FIGURE 1 | ClC-5 expression increases the susceptibility of HEK293 cells toward TcdA and TcdB. (A) HEK293 cells stably transfected with ClC-5-mCherry,
ClC-4, or mCherry alone (mock) treated with 10 pM TcdB for 1 h at 37◦C. The micrographs show the cell morphology of healthy untreated cells (left), as well as cell
rounding induced by toxin-catalyzed glucosylation of the Rac1 GTPase (middle). Enlarged micrograph sections of the toxin-treated cells are depicted in the right lane.
(B) Representative concentration-dependent analysis of Rac1 glucosylation by TcdB. Glucosylation was determined by immunoblotting using glucosylation-sensitive
anti-Rac1 antibody. A decrease of the anti-Rac1 signal (non-gluc Rac1) reports an increase of the glucosylation of Rac1. Beta-actin is used as a control for protein
load. (C,D) Densitometry evaluation of immunoblots as depicted in (B) showing Rac1 glucosylation by TcdB and TcdA (n = 3, mean ± SD). (E) Effects of V-ATPase
inhibition by bafilomycin A1 (baf. A1) on cell rounding induced by toxin-catalyzed glucosylation of Rac1 GTPase. Examined were HEK293 cells stably transfected with
mCherry (mock), ClC-4, or mCherry-tagged ClC-5. Bars represent the percentage of rounded cells at the end of the experiment. Controls were either treated with baf.
A1 (baf. A1) or with 2 nM toxin (TcdB). In the first combination experiment, cells were first treated with baf. A1 for 10min before the toxin (2 nM) was added to show
the maximum inhibitory effect (baf A1 + TcdB). For limited uptake of TcdB, baf. A1 was added 10min after addition of 2 nM toxin (TcdB + baf. A1). Cell rounding was
examined by light microscopy at the end of the experiment (total time 100min at 37◦C, n = 3, mean ± SD).
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inserts showed that the TER decreases faster in ClC-5 expressing
cells exposed to TcdA (Supplementary Figure S2A). For example,
1 h of basolateral toxin application decreased the TER of ClC-5-
expressing cells by approximately 50%. In contrast, a comparable
TER decrease was observed in untransfected cells after 3 h of
TcdA incubation. These effects additionally demonstrate the role
of ClC-5 for the accelerated intoxication by TcdA and indicate
that this ion transporter stimulates the uptake or translocation of
C. difficile toxins.
We next investigated the effects of TcdA and TcdB on
Rac1 glucosylation, the primary cause for the following
cytoskeleton disruption and cell rounding (Just and Gerhard,
2005). Immunoblotting with a glucosylation-sensitive anti-Rac1
antibody (Genth et al., 2006) showed increased glucosylation
in toxin-exposed ClC-5-expressing cells when compared to
mock cells (expressing mCherry). Rac1 glucosylation in ClC-5-
expressing cells was also increased when compared to the effect
in cells stably transfected with ClC-4 (decrease of the anti-Rac1
antibody signal, Figures 1B–D). To additionally demonstrate
that the intoxication specifically shifts the equilibrium between
glucosylated and non-glucosylated Rac1, we also tested how toxin
treatment affects the total amount of Rac (Supplementary Figure
S2B). Please note that the differences in the intensity of the
Rac1 bands shown in Figure 1 and Supplementary Figure S2 are
due to differences of loaded protein amounts and Western Blot
detection.
Based on the role of ClC-5 for vesicular acidification (Jentsch,
2008), we conducted additional experiments in which we applied
the specific V-ATPase blocker bafilomycin A1 (Yoshimori
et al., 1991). High concentration of TcdB (2 nM) was used
in these experiments to maximize toxin uptake. The ATP-
dependent acidification was blocked either 10min before the
application of TcdB to prevent toxin translocation, or 10min
after toxin application to allow limited translocation. The
cytopathic cell rounding was assessed after an additional 90-
min incubation at 37◦C. In the first 10min, cells expressing
mCherry or ClC-4 showed no visible cell rounding which
indicates poor toxin uptake or translocation (Figure 1E). In
contrast, a significant number of cells expressing ClC-5 become
rounded. It is established that bafilomycin interferes mainly
with the pH-dependent early-to-late endosome and the late-
endosome-to-lysosome maturation and not with the preceding
endocytosis steps (Yoshimori et al., 1991; Bayer et al., 1998).
These experiments suggest, therefore, that enhanced rates of
endocytosis and early endosome acidification and maturation
might be decisive for the increased cytopathic effects of large
C. difficile toxins in ClC-5 expressing cells.
The Cytopathic Effect of TcdA Is Reduced
by Knockdown of CLC-5
To provide evidence for the biological relevance of the
accelerated intoxication associated with ClC-5 overexpression,
we used small interference RNA (siRNA) to reduce the
endogenous expression of ClC-5 in colon HT29 cells. The
effectiveness of the method to reduce the number of expressed
ClC-5 proteins was tested on HEK293 cells stably expressing
mCherry-tagged ClC-5. In these experiments, the number of
ClC-5 proteins (measured by themCherry fluorescence intensity)
was clearly reduced 72 h after the transfection (Supplementary
Figure S3A). Similarly, quantitative RT-PCR demonstrated a
relative downregulation of endogenously expressed ClC-5 by
approximately 50–70% in HT29 cells (Supplementary Figure
S3B). In the following experiments, we intoxicated HT29 cells
with 3 nM TcdA and assessed the associated cytopathic effects
by quantifying the percentage of rounded cells. To differentiate
between transfected and untransfected cells, a plasmid containing
the sequence of the human CD8 antigen was cotransfected
together with the siRNA. Commercial microbeads coated with
anti-CD8 antibodies were added to the cell/toxin mixture and
used to visually select transfected cells (see Supplementary
Figure S3C). The downregulation of ClC-5 in these experiments
reduced the toxin potency on HT29 cells by approximately
10% (Figure 2). The significant reduction of the toxin potency
demonstrates the physiological relevance of the ClC-5-mediated
effects and the potential therapeutic importance of altering ClC-
5 activity in gastrointestinal cells. The incomplete block of the
cytopathic effects is not surprising. On the one hand, ClC-5
expression could not be completely blocked by the procedure;
on the other hand, the cellular V-ATPases which are the major
force behind vesicular acidification are expected to be active in
the treated cells. It is arguable that the transfection efficiency of
plasmid DNA and siRNA is not identical and therefore that the
cells expression CD8 antigen are not necessarily also transfected
with siRNA. The RNA downregulation of up to 70% indicates,
however, that more cells are transfected with siRNA than with the
pLeu2-CD8 plasmid (which showed a transfection efficiency of
around 30%). This increases the probability that the pleu2-CD8
expressing cells were also transfected with siRNA.
FIGURE 2 | Downregulation of endogenous ClC-5 decreases TcdA
cytotoxicity. The expression of ClC-5 in HT29 cells was reduced by
transfection with siRNA targeting human ClC-5 (siClC-5). Transfection with
non-targeting RNA was used as a control. Bars represent the quantitative
analysis of the cytotoxic action of 3 nM TcdA (percentage of roundish cells,
See Supplementary Figure S3). Data are summarized as means ± SEM (n = 3
for the control and n = 7, n = 7 for siClC-5 treated cells). *Indicates a
statistical difference; p < 0.05.
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TcdA Colocalizes with CLC-5 in Vesicular
Compartments
A mechanism in which endocytosis and endosomal acidification
enhanced by ClC-5 leads to faster delivery of the enzymatically
active toxin N-terminal domain requires the toxins to localize
in vesicles containing this transporter at least during the initial
internalization phase. To test this hypothesis, we performed
live cell imaging experiments in human colon cancer cells
(cell line HT29) that are often used as a model for the colon
epithelial cells attacked by C. difficile. The transporter was
labeled with a fluorescent tag (mCherry or EYFP) covalently
fused to its carboxy-terminus (Grieschat and Alekov, 2012).
TcdA was visualized using an EGFP fluorescent tag inserted
between the intermediate translocation domain and the C-
terminal combined repetitive oligopeptides (CROPs) domain of
the toxin (Olling et al., 2011). SDS-PAGE analysis confirmed
that HT29 cells express and correctly process transfected ClC-
5 (Figure 3A). Two distinct bands with the expected molecular
weight of around 90 kDa were visible. In accordance with the
established glycosylation of ClC-5 transporter (Jouret et al.,
2004), the upper band represents complex-glycosylated and the
lower band non-glycosylated and core-glycosylated ClC-5. The
toxicity of TcdA was enhanced in these cells upon transfection
with ClC-5 (Supplementary Figure S1). Upon incubation,
fluorescent EGFP-tagged TcdA was detected at the plasma
membrane and in intracellular vesicles in both untransfected
and in ClC-5-expressing HT29 cells (Figures 3B–D). ClC-5 was
localized in intracellular vesicles and a significant colocalization
with internalized toxin was visible (Figure 3D). In contrast,
expression of fluorescently labeled ClC-4 led to staining of the
endoplasmic reticulum and showed no specific localization with
internalized TcdA-EGFP (Supplementary Figure S4). The lower
expression levels of ClC-5 in transfected HT29 cells (Figure 3D,
inset “red”) seem to reflect the fact that this cell line is not
optimized for the processing of plasmid DNA as is for example
the HEK293T cell line.
We next quantified the colocalization between ClC-5 and
TcdA using the Fiji plugin SQUASSH which is superior for
analyzing “asymmetric” data, i.e., data for which many of the
objects containing one of the investigated markers colocalize
with objects containing the second marker but not vice versa.
The analysis is superior also for noisy data (Rizk et al., 2014).
We reasoned that the criteria fit our images since we did not
expect a perfect overlap between the labeled vesicles in the two
fluorescence channels. In particular, it appears unlikely that TcdA
saturates all of the ClC-5-containing vesicles. Moreover, the weak
fluorescence of internalized TcdA-GFP leads to relatively high
noise in the corresponding imaging channel. The workflow of
the analysis is exemplarily presented in Supplementary Figure
S5. The object-based analysis showed that approximately 12%
of the objects identified in the ClC-5 channel colocalized with
TcdA objects (colocalization of 0.12; theoretical minimum–
0 for no colocalization, theoretical maximum–1 for perfect
colocalization); vice versa, approximately 34% of the objects
identified in the TcdA channel colocalized with ClC-5 objects
(Figure 3E, colocalization of 0.34). Using the same plugin, we
also performed size-based analysis calculating the relative volume
of the colocalizing pixels normalized to the full volume of all
identified objects in each channel. The values obtained in this way
were similar to the ones obtained by the object-based strategy:
approximately 16% of the ClC-5 pixels colocalized with TcdA
and approximately 40% of the TcdA pixels colocalized with ClC-5
(Figure 3E).
We also attempted to quantify time-dependent changes of the
colocalization between both fluorophores. After a binding step
with TcdA-EGFP at 4◦C, cells were incubated for 0, 8, or 15min at
37◦C to allow internalization of the toxin. At the specified times,
cells were fixed with methanol or paraformaldehyde to stop
the processing of internalized toxins. Surprisingly, independent
on the type of the fixation procedure, we detected only very
weak EGFP fluorescence in intracellular vesicles (Supplementary
Figure S6). These results resemble the findings of Kern and
Feig (2011) who also reported a low detection of intracellular
EGFP-tagged TcdA. The live-cell experiments (Figure 3) suggest,
however, that a failure to internalize is not responsible for these
effects. This conclusion is also supported by the fact that cell
rounding induced by TcdA-EGFP occurs to a similar extent as if
induced by wild type TcdA, i.e., that the cytotoxicity of the tagged
toxin is preserved. Therefore, the encountered low number of
intracellular vesicle-like spots in these experiments seems to
result from fluorophore bleaching due to the applied fixation
procedures. Significant negative effects of fixatives on the EGFP
fluorophore have been reported by others (Brock et al., 1999;
Billinton and Knight, 2001). In our case, the bleaching/quenching
of internalized EGFP might have been further enhanced by the
low vesicular pH of the endosomes.
Transport Deficient ClC-5 Enhances
Cytopathic Action of TcdA Similarly as the
Transport-Competent Variant
Next, we set out to elucidate the impact of the ClC-5-mediated
electrogenic ion transport for the enhanced action of C. difficile
toxins. Since no potent pharmacological blockers for ClC-5 are
available, we decided to use point mutation E268Q. Glutamate
E268 is positioned near the intracellular protein-water interface
and forms the entry of the separate proton transport pathway
in CLC transporters. This highly conserved glutamate serves as
an intracellular H+-acceptor and is obligatory required for the
coupled exchange of chloride and protons (Accardi et al., 2005).
Neutralizing the electric charge of this glutamate in the bacterial
EcCLC leads to uncoupling of the CLC transport and allows
anions to be transported without the antiport of protons (Accardi
et al., 2005). Analogous charge neutralizations in mammalian
CLC exchangers abolish not only proton but also anion transport
(Zdebik et al., 2008; Smith and Lippiat, 2010b; Grieschat and
Alekov, 2012). In other words, transfecting mutation E268Q
results in the expression of a silent ClC-5 protein that does
not mediate electrogenic ion transport. Surprisingly, however,
overexpression of this mutant was also able to increase the
cytopathic action of TcdA (Figures 4A–C). We hypothesized,
therefore, that mutant E268Q might similarly as WT ClC-
5 enhance the endocytotic toxin uptake. The internalization
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FIGURE 3 | Colocalization of TcdA-EGFP and ClC-5 in living cells. (A) Electrophoresis SDS-PAGE of ClC-5-EYFP. Whole cell lysates of HT29 and HEK293T
cells transiently expressing ClC-5-EYFP were separated by SDS-PAGE electrophoresis (60 µg of HT29 and 30 µg of HEK293T whole protein lysate). The first lane
shows a standardized fluorescent marker with defined molecular weights of the bands indicated in kDa. (B,C) Representative live-cell confocal images (Z- single
Z-section; MIP-maximum intensity projection) of HT29 cells after internalizing TcdA-EGFP for intervals ranging from 6 to 15min at room temperature (RT). (D)
Representative live-cell dual color confocal image showing the localization of TcdA-EGFP and ClC-5-mCherry in HT29 cells. Cells transiently expressing
mCherry-tagged ClC-5 (red) were incubated with TcdA-EGFP (green) for an interval of 6–10min at RT. All images were obtained using a spinning disc confocal
microscope. (E) Box plots summarizing the results from an object- (left) and size-based (right) colocalization analysis of images as depicted in (D) corresponding to
the number of overlapping objects and the overlapping areas of the objects identified as ClC-5- and TcdA-containing objects. Six cells were analyzed [single cells (•),
25–75% (¨, large box), mean (♦), median (─) as well as 99and 1%, respectively (X)]. Scale bars correspond to 10 µm.
in this case might utilize different endocytosis pathway and
the underlying process might not obligatory depend on the
electrogenic transport function of the protein. To test this
hypothesis, we investigated the effects of a truncated TcdA
peptide in which the domain containing the so-called combined
repetitive oligopeptides (CROPs) is removed (Papatheodorou
et al., 2010; Olling et al., 2011; Gerhard et al., 2013). This
deletion greatly reduces toxin uptake and the modified peptide
seems to be internalized by a pathway that differs from the one
followed by WT TcdA (Gerhard et al., 2013). Its application
allows testing whether the toxin internalization proceeds more
effectively along this alternative pathway in cells expressing ClC-5
E268Q. However, intoxication induced by the CROPs-truncated
TcdA (TcdA 1-1874) was similarly enhanced by both ClC-5 WT
and ClC-5 E268Q (Figures 4A–C, right). ClC-5 WT and E268Q
seem, therefore, not to enhance different endocytosis pathways.
To directly compare the effects of both ClC-5 constructs on
endocytosis, we quantified the amount of toxin that is bound and
internalized during a 5-min incubation at 37◦C. The experiment
showed that whereas both ClC-5 WT and ClC-5 E268Q increase
the uptake of TcdA, the transport-deficient mutant is half
as effective in doing so (Figure 5, Supplementary Figure S7;
approximately 5-fold increase for ClC-5 WT vs. approximately
2.5-fold for ClC-5 E268Q). This effect might be explained, for
example, by postulating that mutant E268Q ClC-5 is less effective
in enhancing the overall rate of endocytosis. Unfortunately, there
is no mouse model for the E268Q mutant, but mice expressing
the uncoupling mutation of the proton glutamate E211A show
impaired renal endocytosis (Novarino et al., 2010). Together
with the experiments with CROPs-deleted TcdA, these results
suggest that accelerated endocytosis rate is probably not the only
explanation for the enhanced cytotoxicity associated with ClC-5.
Transport Competent and
Non-transporting CLC-5 Similarly Support
Endosomal Acidification
Theoretical considerations by us have shown that the increased
membrane capacitance resulting from the expression of E268Q
would decrease the energy barrier opposing V-ATPase proton
pumping into the endosomal lumen (Guzman et al., 2013).
Therefore, we next measured vesicular pH in mock-transfected
cells and in cells expressing ClC-5 WT or mutant E268Q.
We used the ratiometric pH indicator 8-hydroxypyrene-1,3,6-
trisulfonic acid (HPTS) that labels intracellular vesicles upon
internalization (Overly et al., 1995). EndocytosedHPTS exhibited
a high degree of colocalization with ClC-5 (Figure 6A). The
dye is characterized by its dual-peak excitation spectrum with
a real pH-independent isosbestic point and a left and right
shoulders that become higher and lower upon acidification,
respectively (Overly et al., 1995). The HPTS-basedmeasurements
showed that vesicular pHs in cells expressing ClC-5 WT and
ClC-5 E268Q do not differ from each other and are both
significantly lower than the one measured in cells not expressing
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FIGURE 4 | Increased TcdA susceptibility of ClC-5 transfected cells is independent of electrogenic H+/Cl− antiport. (A) HEK293 cells stably transfected
with the fluorescent mCherry (mock), ClC-5-mCherry and ClC-5-mCherry E268Q were treated with 0.3, 1, and 3 nM of full length TcdA (left) or CROPs-truncated
(right) TcdA 1-1874. The micrographs depict cell rounding induced by toxin-catalyzed glucosylation of Rac1 GTPases. (B) Representative concentration-dependent
analysis of Rac1 glucosylation by TcdA or TcdA 1-1874. Glucosylation kinetics was determined by immunoblotting using glucosylation sensitive anti-Rac1 antibody. A
decrease of the Rac1 signal (non-gluc Rac1) correlates with the extent of glucosylation. (C) Concentration-dependent cytopathic effect of TcdA or TcdA 1-1874 on
ClC-5- or ClC-5 E268Q expressing cells, measured by calculating the proportion of roundish cells to cells with healthy morphology.
ClC-5 (Figure 6, Supplementary Figure S8). To additionally
test the validity of the results, we performed experiments in
which the genetically-encoded vesicular pH reporter synapto-
pHluorin2 was used (Miesenböck et al., 1998; Alekov, 2015).
These measurements confirmed that vesicular pH in cells
expressing the mutant is lower than the one in cells expressing
only synapto-pHluorin2 (Figures 6C,D, Supplementary Figure
S8). Thus, transport incompetent ClC-5 E268Q is also capable of
enhancing vesicular acidification.
Previous experiments by Smith and Lippiat addressed how
a similar mutation, ClC-5 E268A, affects endosomal pH. They
also found that the endosomal pH of cells expressing the mutant
is lower compared to untransfected cells (Smith and Lippiat,
2010a). The smaller magnitude of the observed differences in
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FIGURE 5 | ClC-5 and ClC-5 E268Q enhance the internalization of
TcdA. HEK293 cells stably transfected with the fluorescent mCherry (blue),
ClC-5-mCherry (WT, black) and ClC-5-mCherry E268Q (red) were treated for
45min on ice followed by a 5-min incubation at 37◦C with 200 nM TcdA
labeled with an Atto425. TcdA uptake was assessed by the Atto425
fluorescence intensity excited at 425 nm and measured at 440–650 nm. To
correct for the different number of cells in the individual experiments, cell
density was additionally measured using by absorbance spectrophotometry
(Supplementary Figure S5). 9 Petri dishes were analyzed for ClC-5 WT and
E268Q and 10 for mCherry on two different days. Bars represent means
±SEM at 490 nm emission. * Indicates a significant difference between two
data sets. The significance was tested using a two-tailed t-test and
significance was set at a P-value of <0.05.
their experiments could be due to lower expression levels.
Moreover, an obligatory colocalization between ClC-5 and the
pH probe pHluorin, as implemented here by us, was not imposed
in this case (Smith and Lippiat, 2010a). It is possible, therefore,
that some of the vesicles analyzed by the authors contained only
a small number of ClC-5 transporters. Such effects would lead to
an underestimation of the acidifying action ClC-5 E268A.
CLC-5 Is Associated with Markers of Early
Endosomes in Colon Epithelial HT29 Cells
We next mapped the ClC-5-dependent internalization pathway
in HT29 cells by quantifying the colocalization of ClC-5 with
proteins of the Rab family that reside in different endosomal
subpopulations. In kidney epithelia, ClC-5 is found in the same
vesicles as the constitutively active (CA) form of Rab5, a small
GTPase residing mainly in early endosomes (Günther et al.,
1998).
We, therefore, started our investigations with this variant but
also tested the dominant negative (DN) and wild-type (WT)
Rab5. Analysis of the confocal images showed that ClC-5 exhibits
the highest colocalization with Rab5 CA, a weaker but significant
colocalization with Rab5 WT and the lowest colocalization with
Rab5 DN (Supplementary Figure S9). Supplementary Figure
S10 shows that ClC-5 also colocalizes with the early-to-late
endosomal marker Rab7 (Feng, 1995) and with another often-
used early endosomal marker Rab4a (Sönnichsen et al., 2000).
Rab4 is known to localize to both the vacuolar and
budding compartment of early endosomes (Sönnichsen et al.,
2000) whereas Rab5 localizes predominantly to the vacuolar
subpopulation (Trischler et al., 1999; Sönnichsen et al., 2000).
The colocalization with several Rab proteins suggests that in
colon HT29 cells, ClC-5 is localized to a broad subpopulation
of intracellular vesicles, including the early (Rab4 and Rab5)
and early-to-late endosomes (Rab7). In contrast, very weak
colocalization of ClC-5 with the marker for recycling endosomes
Rab11 (Ullrich et al., 1996; Sönnichsen et al., 2000) was visible
(Supplementary Figure S10).
ClC-5 has been also shown to directly interact with the
microtubule motor kinesin2 (Reed et al., 2010). We, therefore,
imaged cells expressing both, the microtubule marker EMTB1
and ClC-5. In these cells, some of the ClC-5 containing
endosomes appeared in the proximity of stained microtubules
(Supplementary Figures S10E,F).
In light of the effects of the non-transporting mutation
E268Q ClC-5, we also checked whether mutation E268Q exhibits
different localization in HT29 cells (Supplementary Figure S11).
However, it showed similar localization as the WT and seems,
therefore, to preserve the intracellular localization of ClC-5. In
summary, ClC-5 appears to enhance the cytotoxicity of C. difficile
toxins by accelerating endocytosis and endosomal acidification
in a manner that does not depend on its ion transporting
capabilities.
DISCUSSION
The major virulence factors of pathogenic C. difficile are two
large toxins, TcdA and TcdB, that invade host cells via the
endocytotic route and disrupt the gastrointestinal epithelial
barrier (Jank et al., 2007; Papatheodorou et al., 2010; Pruitt
et al., 2010). The acidification of endocytotic organelles is
crucial for the intracellular translocation with subsequent
release of the enzymatically active N-terminus into the cytosol
(Qa’Dan et al., 2000). We here investigated the role of the
anion/proton exchanger ClC-5 for the cytotoxicity caused by
TcdA and TcdB. ClC-5 is expressed in gastrointestinal epithelia
and is one of the key molecular determinants supporting
vesicular acidification along the endocytotic pathway. Our
data show that ClC-5 expression dramatically increases the
susceptibility to intoxication by both TcdA and TcdB (Figures 1,
4, Supplementary Figure S1). These findings are specific for ClC-
5 since such potent effects were not observed (see Figure 1) in
cells stably expressing the fluorescent protein mCherry alone,
or ClC-4, a closely related intracellular CLC transporter that
functions similarly as ClC-5 (Guzman et al., 2013) but is localized
mainly in membranes of the endoplasmic reticulum (Okkenhaug
et al., 2006). The specificity of the effects and their biological
relevance is further demonstrated by the reduced cytopathic
effect of TcdA associated with the knockdown of endogenously-
expressed ClC-5 (Figure 2). These findings, together with the
previously demonstrated physiological role of ClC-5 in human
gastric epithelia (Sullivan et al., 2009; Alex et al., 2010; Takahashi
et al., 2014), outline ClC-5 as a potential critical part of the host
cell machinery attacked and hijacked by C. difficile toxins in
the processes of cell invasion, cell intoxication and cell killing.
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FIGURE 6 | ClC-5 overexpression promotes endosomal acidification in HEK293 cells. (A) Localization of endocytosed HPTS dye (right panel, green) and
ClC-5 mCherry (right panel, red) in live HEK293 cells, with superimposed fluorescence images in red and green resulting in yellow at colocalization. (B) HEK293 cells,
stably expressing ClC-5 mCherry, the non-transporting ClC-5 E268Q mCherry, or mCherry alone were incubated with 100 µM HPTS for 24 h and the fluorescence at
510 nm was recorded upon excitation at 350–500 nm in a Horiba Fluorolog spectrophotometer. Intensities are normalized to the isosbestic point at 414 nm. The inset
displays the pH obtained by calculating the ratio of the HPTS fluorescence at 510 nm exited at 450 and 390 nm, respectively and converting it to pH using an
empirically constructed calibration curve (Supplementary Figure S6). Results are presented as mean ±SEM (n = 4, *p < 0.05). (C) Representative HEK293T cells
transiently transfected with ClC-5 mCherry (red) and synapto-pHluorin2 (green). (D) Analysis of vesicular pH of HEK293T cells transiently co-expressing mCherry
tagged ClC-5 or ClC-5 E268Q and synapto-pHluorin2 or solely expressing synapto-pHluorin2. The pH was determined using an empirically constructed calibration
curve (Supplementary Figure S6). Results are shown as means ±SEM. *Indicates a significant difference between two data sets with p < 0.05 (n = 46 cells for ClC-5,
n = 44 for ClC-5 E268Q and n = 34 cells for synapto-pHluorin2). Scale bars correspond to 10 µm.
Moreover, our findings suggest that the increased expression of
ClC-5 associated with IBD (Sullivan et al., 2009; Alex et al., 2010)
might be one of the factors leading to the higher incidence,
increased severity and higher mortality rates observed upon C.
Difficile infections (CDI) in patients with IBD (Issa et al., 2008).
At the cellular level, defects of ClC-5 have been demonstrated
to impair both receptor-mediated endocytosis and vesicular
acidification in mouse kidney (Jentsch, 2008) and in human
cells (Gorvin et al., 2013). We performed several additional
experiments to test how these two effects enhance the action
of C. difficile toxins. Firstly, we investigated the effects of ClC-
5 on intoxication by TcdA with ablated CROPs domain (TcdA
1-1874, Figure 4). It is known that TcdA can enter cells via
different endocytosis routes that are differentially affected when
the CROPs domain is removed (Papatheodorou et al., 2010;
Olling et al., 2011; Gerhard et al., 2013). The general increase
in susceptibility due to ClC-5 observed for TcdA, TcdB and
for the CROPs-truncated variants (Figures 1, 4) suggests that a
selectively enhanced internalization via one of these pathways
is probably not the only mechanism behind these effects. This
notion is supported by the fact that ClC-5 expression increases
the cytotoxicity of TcdA applied at both the basolateral and the
apical side of polarized epithelial cells (Supplementary Figure
S2A). In addition, we showed that ClC-5-mediated enhancement
of the TcdB cytopathic effects is reversed by preincubation
with bafilomycin A1 (Figure 1) that does not block the initial
endocytotic steps (Yoshimori et al., 1991; Bayer et al., 1998). This
observation outlines the importance of vesicular acidification
for the increased susceptibility induced by ClC-5. Thirdly,
quantifying the rate of endocytosis showed that it is accelerated
to a higher extent by the expression of ClC-5 WT than by the
expression of ClC-5 E268Q (Figure 5). In contrast, the cytopathic
action of C. difficile toxins was enhanced to a similar extent for
the two ClC-5 constructs (Figure 4). Finally, the intravesicular
pH is lowered to the same extent in cells expressing ClC-5 WT
or the non-transporting ClC-5 E268Q. These results represent
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compelling evidence that ClC-5 increases the susceptibility to
TcdA and TcdB by lowering the pH of the early endosomes
and by promoting their maturation. Interfering with this process
seems, therefore, a promising strategy for treating or preventing
CDI. Unfortunately, proton pump inhibitors have been shown
to increase the risk of CDI, probably due to inhibitory effects on
the growth of the normal bacterial gut flora (Sharma et al., 1984;
Jonkers et al., 1996; Howell et al., 2010; Janarthanan et al., 2012).
The identification of ClC-5 as a mammalian protein potentially
involved in the internalization and activation of C. difficile toxins
underlines, therefore, the need for discovering, characterizing
and testing specific inhibitors or modulators of this transporter
in gastrointestinal epithelia.
An additional important finding reported here is the ability
of mutant ClC-5 E268Q to support vesicular acidification
and accelerate intoxication by TcdA and TcdB to a similar
extent as ClC-5 WT (Figures 4, 6). To our knowledge, this
is the first report describing the physiological impact of this
non-transporting ClC-5 mutant. In addition to abolishing
electrogenic transport, mutation E268Q also increases the electric
membrane capacitance (Grieschat and Alekov, 2012). As such, it
is capable of reducing the positive electric potential build up by
the proton pumping action of the V-ATPases, i.e., it allows more
protons to be transported into the vesicular lumen in expense for
the same amount of hydrolyzed ATP (Guzman et al., 2013). The
capacitive currents accompanying the activation of mammalian
CLC transporters seem, therefore, to be not merely a byproduct
of their voltage-dependent gating. In contrast, they might serve
distinct and important physiological functions, similar to the
capacitance alternations associated with the gating of neuronal
cation channels (Hodgkin, 1975). These results suggest that the
invasion and processing of bacterial toxins directly depend on the
physical properties of the endosomal membrane. Accordingly,
age and developmental changes are to be expected. Of note,
reduced risk of CDI is observed in patients taking statins,
but not other cholesterol-lowering drugs (Naggie et al., 2011;
Motzkus-Feagans et al., 2012). As cholesterol is well known
to increase the electric capacitance of the lipid bilayer, the
aforementioned effects might be due to a reduced acidity of
endosomal compartments in these patients. It appears, therefore,
interesting to elucidate whether statins alter more potently the
cholesterol content of endosomal membranes than of the plasma
membrane and whether endosomal pH is indeed altered upon
statin treatment.
The ability to support vesicular acidification was recently
reported for an analogous non-transporting mutant in another
CLC transporter, ClC-7, that regulates acid secretion in the
ruﬄed border of bone-resorbing osteoclasts (Weinert et al.,
2014). It is also interesting that transfecting mutant E268Q ClC-
5 enhances toxin internalization to a lesser extent compared to
WT ClC-5. A physiologically relevant link between intravesicular
Cl− content and endocytosis has been established previously
(Novarino et al., 2010). Therefore, the lower toxin uptake (when
compared to the uptake in cells expressing ClC-5 WT) might be
attributed to an alteration of the intravesicular Cl− concentration
that originates from the non-transporting phenotype of mutant
E268Q. Investigating if the corresponding mutant in ClC-7 also
increases the membrane capacitance might clarify whether its
pathophysiological impact (Weinert et al., 2014) also relies on
effects resembling the ones described here by us. Electrogenic
ClC-5 transport has been shown to supports the very initial
V-ATPase-independent vesicle acidification, immediately after
their formation. The underlying mechanism seems to be direct
ClC-5 proton transport into the vesicular lumen coupled to
the extrusion of Cl−. (Smith and Lippiat, 2010a) The similarly
high intoxication rates observed for cells expressing transport-
competent and incompetent ClC-5 suggests, therefore, that not
the very initial endocytotic steps but accelerated endosomal
maturation underlies the enhanced effects of C. difficile toxins.
In summary, our findings provide strong evidence that host
intracellular ion transporters, and in particular ClC-5, facilitate
the processing of C. difficile toxins and enhance thereby their
cytopathic action. These novel insights into the cellular role of
ClC-5 and its ability to enhance the virulence of C. difficile toxins
in gastrointestinal cells reveal additional molecular targets at the
host side that are potentially hijacked by pathogen bacteria and
widen the horizon of possibilities for much-needed therapies of
life-threatening gastrointestinal bacterial infections.
MATERIALS AND METHODS
Constructs, Cell Culture, and Protein
Expression
The assembly of the used pRcCMV ClC-4 and pRcCMV ClC-
5 constructs is described in detail previously (Hebeisen et al.,
2003; Grieschat and Alekov, 2012; Guzman et al., 2013). For
creating stable ClC-5-expressing MDCK II cells under blasticidin
selection, the DNA fragment coding for ClC-5-mCherry was
subcloned into the pCDNA6 vector by PCR. The mRFP-Rab5
construct was kindly provided by Ari Helenius (Addgene plasmid
#14437) (Vonderheit and Helenius, 2005). The Rab5 mutants
mCherry-Rab5DN (S34N) and mCherry-Rab5CA (Q79L) were
provided by Sergio Grinstein (Addgene plasmid #35139 and
#35138) (Bohdanowicz et al., 2012). EGFP-Rab4a was kindly
provided by Marino Zerial (University of Technology, Dresden)
(Vitale et al., 1998). EGFP-Rab11 WT and EGFP-Rab7 WT
were provided by Richard Pagano (Addgene plasmid #12674
and #12605) (Choudhury et al., 2002) and the construct EMTB-
3xGFP by William Bement (Addgene plasmid#26741) (Miller
and Bement, 2009). The synapto-pHluorin2 construct was kindly
provided by Dr. Raul Guzman (FZ Jülich, Jülich, Germany) and
used as described previously (Alekov, 2015).
HT29 cells (ATCC #HTB-38) were cultivated in full medium
containing Dulbecco’s MEM/ Hams F-12 (Biochrom), 50
units/ml penicillin/streptomycin (Invitrogen) and 10% FBS
(Gibco) and transfected using the jetPRIME transfection
reagent (Polyplus Transfection) according to the manufacturer’s
protocol. HEK293T cells (ATCC #CRL-3216) were maintained in
DMEM (Gibco), supplemented with 10% FBS (Gibco), 2 mM L-
glutamine and 50 units/ml penicillin/streptomycin (Invitrogen)
and transfected using calcium phosphate precipitation (Graham
and van der Eb, 1973). HEK293 cells (ATCC #CRL-1573),
permanently expressing mCherry-tagged ClC-5 WT or ClC-5
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E268Q and ClC-4 and mCherry alone, as well as MDCK II cells
(ATCC #CRL-2936) permanently expressing mCherry-tagged
ClC-5 WT, were created as described previously (Hebeisen
et al., 2003) and cultivated in minimum Eagle’s medium (MEM)
(Gibco), supplemented with 10% FBS (Gibco) and 900 µg/ml
Geneticin (G418, Invitrogen) or 1 µg/ml blasticidin for MDCK
II cells. HEK293T cells were transfected using the calcium
phosphate precipitationmethod. For transiently transfected cells,
fluorescence imaging was performed 24–48 h after transfection.
Expression, Purification, and Labeling of
TcdA
TcdA and TcdB, as well as their truncated forms and fusion
proteins, were recombinantly expressed as 6xHis-tagged proteins
using the Bacillus megaterium expression system as described
before (Burger et al., 2003). The TcdA-EGFP fusionwas generated
as previously described by Olling et al. by fusion of TcdA 1-
1874 and the N-terminally EGFP tagged CROPs (aa 1,875–
2,710) (Olling et al., 2011). All Proteins were purified by gravity
flow by Ni-affinity chromatography using Ni-TED columns
(Macherey & Nagel) following the standard protocol supplied
by the manufacturer. The specific protein concentration of the
toxins was estimated by SDS-PAGE. To fluorescently label the
primary amino groups of TcdA, the Atto425 Protein Labeling Kit
(Jena Bioscience GmbH) was used following the manufacturer’s
protocol.
C. difficile Toxin Internalization and
Cytopathic Effects Associated with Cell
Morphology
To investigate the internalization and localization of the major
C. difficile toxins, HT29, HEK293T and HEK293 cells were
grown on glass coverslips coated with Poly-L-lysine (Sigma-
Aldrich). 300 µL of Leibovitz L-15 medium (Gibco) containing
200 nM EGFP-tagged TcdA was added to the cells and the
mixture was incubated on ice for 30min during which the
toxins bind to the cells without being internalized. Cellular
uptake of the toxin was initiated by transferring the cell/toxin
mixture to 37◦C or room temperature. At indicated time points,
the reaction was stopped by removing the toxin-containing
solution and washing with ice-cold PBS (Gibco). For live-cell
imaging, the coverslips containing the intoxicated cells were
transferred in Tyrode’s solution (150mM NaCl, 5mM KCl,
1mM MgCl2, 10 mM HEPES, and pH 7.4) and imaged on a
spinning disc confocal microscope (see below). Alternatively,
cells were fixed using methanol (10min at −20◦C) or 4% PFA
diluted in PBS (15min at RT), washed three times with PBS and
mounted on a microscope slide with 15–20 µL of Fluoromount-
G medium (SouthernBiotech). Fixed cells were imaged using a
laser scanning Zeiss LSM780 microscope (see below).
Endocytosis rate and vesicular acidification capacity of ClC-4
and ClC-5 transformed HEK293 cells was estimated by limited
uptake of TcdB. Abrogation of toxin uptake was achieved by
bafilomycin A1-mediated inhibition of v-ATPase. To this end,
cells were treated with high concentration of TcdB (2 nM in cell
culture medium) to saturate surface receptors and toxin uptake
was allowed for 10min. Then, pH-dependent translocation
process of TcdB from endosomes to cytosol was terminated by
addition of bafilomycin A1 (100 nM). The translocation capacity
of cells was estimated by quantification of rounded cells after
further 90min incubation. Proof of bafilomycin A1-mediated
inhibition of TcdB effects was given by 10min preincubation
of cells before application of TcdB. Maximum cytopathic effect
(cell rounding) was shown by incubation of cells with 2 nM TcdB
alone.
To measure the amount of internalized TcdA, the primary
amino groups of full-length TcdA were labeled using the Atto425
Protein Labeling Kit (Jena Bioscience GmbH) according to
the manufacturer’s protocol. HEK293 cells stably expressing
mCherry, ClC-5 mCherry or ClC-5 E268Q mCherry were
incubated on ice in Leibovitz medium for 15min. Then the
medium was replaced by Leibovitz L-15 medium containing
200 nM TcdA and incubated on ice for 45min. To allow toxin
internalization, the cells were transferred to 37◦C for 5min and
the unbound toxin was washed off three times with PBS (Gibco).
Finally, cells were resuspended in 2mL Tyrode solution and
the fluorescence of the labeled TcdA was analyzed at 425 nm
excitation and an emission of 440–650 nm in a Horiba Fluorolog
spectrophotometer. Afterward, the absorbance of the samples
was measured at 560 nm using a Victor3 multilabel reader. To
determine the number of cells in the sample, calibration curves
for the absorbance at 560 nm for each cell line were performed.
Subsequently, cells were separated using 0.25% Trypsin-EDTA
(Gibco) and resuspended in medium. After a centrifugation step
at 300 × g for 3min, cells were washed once with PBS (Gibco)
and centrifuged again (3min at 300 × g). Subsequently, cells
were resuspended in 3 ml Tyrode solution and counted using a
Neubauer chamber.
For the cytotoxicity assay, cells were seeded in 24-well
chambers and grown for 24 h to sub-confluence. Toxins were
diluted in cell culture medium at various concentrations and
added to the cells. Toxin-induced cell rounding wasmonitored by
light microscopy and the cytopathic effect was quantified as the
percentage of rounded cells compared to the total cell number.
For all experiments with a direct comparison between effects,
toxin from the same preparation batch was used to avoid possible
activity differences.
ClC-5 siRNA Knockdown
To reduce the levels of ClC-5 in HT29 and HEK293 cells, the
ON-TARGETplus Human CLCN5 (1,184) siRNA SMART
pool (Dharmacon, #L-006153-00-0005) was used. One day
before transfection, cells were seeded on glass pre-coated with
Poly-L-lysine (Sigma-Aldrich). 10 nM and 20 nM of siRNA were
transfected. For microscopic analysis of cells intoxicated with
TcdA, a plasmid caring the coding sequence of the leucocyte
antigen CD-8 was cotransfected. To verify the knockdown of
ClC-5, RNA was extracted using the Isol-RNA Lysis Reagent
(5PRIME). Cells were scraped off the plate and washed once
with PBS. Then Isol-RNA Lysis Reagent was added and
RNA was extracted according to the manufacturer’s protocol.
The integrity of the RNA was checked on an 2% agarose
gel and its concentration was measured using a Nanodrop
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Photometer (Thermo Fischer Scientific). To remove genomic
DNA contamination, a DNase I digestion was performed
using the RQ1 RNase-Free DNase (Promega) according to the
protocol. cDNA was generated with the AMV First Strand
cDNA Synthesis Kit (New England BioLabs). Finally, the
level of ClC-5 mRNA was analyzed using appropriate forward
(GGGGCTATTTGGGTAAGTGGACTC) and reverse primers
(GCAAAGAATGAACGCCACAAT). Expression levels were
normalized to the housekeeping gene phosphoglycerate kinase
1 (PGK1) (Jacobsen et al., 2014). For PGK1, the forward
(GAGATGATTATTGGTGGTGGAA) and reverse primers
(AGTCAACAGGCAAGGTAATC) were used. A quantitative
RT-PCR was carried out using PowerUP SYBR Green Master
Mix (Thermo Fisher Scientific) in triplicates with ClC-5 and
PGK1 primers. The expression levels of ClC-5 were normalized
to PGK1 levels and the 2−11CT was calculated (Livak and
Schmittgen, 2001). To validate the knockdown not only on the
mRNA level but also on the protein level, HEK293 cells stably
transfected with mCherry-tagged ClC-5 were transfected with
the siRNA and after 72 h the fluorescence of the ClC-5-mCherry
protein was investigated.
To analyze the cytopathic effect of TcdA on HT29 cells with
reduced levels of ClC-5, cells were incubated with 3 nM TcdA
(3 h at 37◦C) 72 h after the transfection, and the percentage of
rounded cells to cells with healthy morphology was calculated.
To identify HT29 cells with a high probability of transfection
with siRNA, cells were cotransfected with a plasmid encoding
the CD8 antigen and incubated before use with polystyrene
microbeads pre-coated with anti-CD8 antibodies (DynabeadsM-
450 CD8, Dynal) (Jurman et al., 1994). Only cells decorated
with microbeads (see Supplementary Figure S3C) were then
analyzed for rounding. In a blinded control test, the rounding
of cells carrying beads was analyzed in parallel by J. Bleidorn.
The outcome of the test was identical, excluding possible bias
introduced by the investigator.
Measurement of Transepithelial Electrical
Resistance (TER)
TER measurements were performed as described previously
(Gerhard et al., 1998). In brief, cells (untransfected or stably
transfected with mCherry-tagged ClC-5) were seeded onto filter
inserts (Nunc) at a density of 105 cells per cm2. Cells were then
grown for 5 days to build a differentiated monolayer. The TER
was measured using an EVOM volt/ohm meter equipped with
an EndOhm chamber (World Precision Instruments). Only cell




Live cells were imaged on an Olympus BX61WI microscope
equipped with a Yokogawa CSU-XI spinning disc unit. mCherry
was excited at 561 nm, EYFP at 515 nm, EGFP and the Atto425
labeling dye at 445 nm. Fluorescence was detected using a filter
set with a GFP emitter of 537/26 nm (also used for YFP detection)
and mCherry emitter of 609/54 nm. A Zeiss LSM 780 confocal
laser scanning microscope was used for imaging of fixed cells
and for the measurement of endosomal pH in living cells. EGFP
was excited at 488 nm and mCherry at 561 nm. Emission was
recorded between 493 and 574 nm (EGFP) as well as 578–696 nm
(mCherry). For testing the localization of HPTS, the dye was
excited at 405 nm and emission was detected at 490–520 nm
together with mCherry excited at 561 nm and 578–696 nm.
Synapto-pHluorin2 was excited at 405 nm and 488 nm; emission
was recorded at 494–574 nm. The autofluorescence intensity of
untransfected and untreated cells was determined in each of
the channels and used to ensure the specific detection of the
transfected proteins or internalized fluorescent labels.
For colocalization analysis, dual color fluorescence images
were subjected to linear spectral unmixing (Zimmermann, 2005).
For the object based colocalization analysis, the Fiji plugin
SQUASSH was used (Rizk et al., 2014). The following optimized
parameters were applied: “background removal” true, “window
size” 10, “regularization” 0.05, “min intensity ch1” 0.05, “min
intensity ch2” 0.05, “subpixel” true, “cell mask ch1” true, “mask
threshold ch1” 0.0145 for fixed cells (0.0011 for Atto425 labeled
toxin and 0.0059 for live cell images of GFP-tagged TcdA), “cell
mask ch2” true, “mask threshold ch2” 0.0049 (0.001 for Atto425
labeled toxin and 0.0072 for live cell images of GFP-tagged
TcdA), “intensity estimation automatic noise model” Poisson.
Parameters used for analyzing cells expressing ClC-5 or ClC-
5 E268Q cotransfected with various Rab variants: “background
removal” true, “window size” 10, “regularization” 0.05, “min
intensity ch1” 0.15, “min intensity ch2” 0.15, “subpixel” true,
“cell mask ch1” true, “mask threshold ch1” 0.0066–, “cell mask
ch2” true, “mask threshold ch2” 0.0049, “intensity estimation
automatic noise model” Poisson. 3D Z-stacks were used for all
colocalization analysis.
SDS-PAGE of Whole Cell Lysate and
Immunoblotting
Twenty four hour after transfection, cells were washed twice with
PBS, scraped off the Petri dishes and resolved in 1 mL PBS.
Cells were then washed by centrifugation (10 s, 100 × g) and
resuspended in 1 mL PBS. Finally, the pellet was dissolved in
100 µL lysis buffer (150mM NaCl, 10mM HEPES, 1% Triton,
1% vol. Complete Protease Inhibitor Cocktail (Roche, freshly
added), pH 7.5). The suspension was incubated on ice for 45min
with a 10-s vortex step every 5min followed by a centrifugation
step for 15min at 13,000 rpm and 4◦C. The supernatant was
transferred into a new collection tube and quantified using a
Bradford assay (Bradford, 1976). The samples were analyzed
by Laemmli gel electrophoresis with 10% SDS running gel
layered with a 4% stacking gel (Laemmli, 1970). The bands of
fluorescence-tagged ClC-5 and the used protein ladder (Spectra
Multicolor Broad Range Protein Ladder, Thermo Scientific)
were imaged with a fluorescence scanner (FUSION SL, Vilber
Lourat). Intracellular glucosylation of substrate GTPases by TcdA
or TcdB was quantified by Western blot using glucosylation-
sensitive monoclonal Rac1-antibody clone 102 (Transduction
Laboratories BD) (Genth et al., 2006). For graphical analysis,
Western blot signal intensity was analyzed densitometrically.
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Rac1 signals were normalized to the Rac1 signals of the untreated
samples. Beta-actin was used as housekeeping protein and
marker for total protein load and detected with a monoclonal
antibody (clone AC15, Sigma-Aldrich).
Measurement of Vesicular pH
For HPTS-based measurements of vesicular pH, HEK293 cells
permanently expressing mCherry-tagged ClC-5 WT, mutation
E268Q or mCherry alone were incubated for 24 h in culture
medium supplemented with 100 µMHPTS (AnaSpec, Inc). Cells
were rinsed twice with PBS, separated using 0.25% Trypsin-
EDTA (Gibco) and washed (centrifugation for 3min at 1,200
rpm, removal of supernatant and resuspension of the pellet)
once in medium and twice in PBS to remove the extracellular
dye. After the final washing step, cells were resuspended in
Tyrode’s solution and the fluorescence of internalized HPTS was
measured in a Horiba Fluorolog spectrophotometer. Excitation
spectra from 350 to 500 nm were recorded at 510 nm emission.
To generate a calibration curve, HEK293T cells were separated
and washed as described above. Then the cells were resuspended
in hypoosmotic buffer (150 mOsm, Tyrode solution diluted 1:2)
containing 0.5mM HPTS. The mixture was then incubated at
37◦C for 1 h. Afterward, the cells were washed 3 times with
buffers having a pH ranging from pH 5 to 8 (15mMMES/HEPES,
130 mM KCl). For the last washing step (centrifugation for
3min at 300 × g), pH Buffer containing 10 µM nigericin (A.G.
Scientific, Inc.) was used and the mixture was incubated for
10min before the HPTS fluorescence was measured. Intensities
were normalized to the isosbestic point at 414 nm.
The measurement of vesicular pH in HEK293T cells
transiently co-expressing synapto-pHluorin2 and mCherry-
tagged WT or E268Q ClC-5, as well as the construction of
a calibration curve, were conducted as previously described
(Alekov, 2015). In brief, cells were illuminated at 405 and
488 nm to excite synapto-pHluorin2 and at 561 nm for mCherry
with emission ranges of 494–574 nm and 578–696 nm. Vesicular
regions were selected using semi-automated analysis in the ClC-5
channel (when co-expressed) or in one of the pHluorin2 channels
for measuring the vesicular pH of cells transfected only with
the pH-reporter construct. The fluorescence ratio F488/F405 was
calculated and converted to absolute pH using an experimentally
determined calibration curve. For the latter, cells transiently
expressing synapto-pHluorin2 were bathed in Tyrode’s solutions
containing 10 µM nigericin (A.G. Scientific, Inc.) with different
acidities and illuminated at 488 and 405 nm. The fluorescence
from membrane regions in the two excitation channels was used
to calculate the ratio F488/F405.
Data Analysis and Statistics
Graphical visualization and statistics of endpoints for evaluation
of toxic effects (cell rounding, Rac1-glucosylation) were
performed with GraphPad Prism 5.02 (GraphPad Software).
The rest of the data were analyzed and graphed using Excel
(Microsoft), Origin (MicroCal), and MatLab (MathWorks).
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